GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
161.51
+0.69 (0.43%)
Dec 10, 2025, 1:04 PM EST - Market open
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $4.67 billion as of December 10, 2025. Its market cap has increased by 135.79% in one year.
Market Cap
4.67B
Enterprise Value
4.51B
1-Year Change
135.79%
Ranking
Category
Stock Price
$161.51
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $4.67B, a decrease of -73.92%. That is a compound annual growth rate of -23.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 4.65B | 120.15% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | 20.16B | 12.65% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |